Specialty Care Providers

Combating Specialty Drug Challenges in the Pharmaceutical Industry

December 19, 2023 - The pharmaceutical industry has witnessed a significant rise in the utilization of specialty drugs in recent years, prompting a need for improved cost management and a streamlined patient experience. Specialty drugs, characterized by their high costs, complexity, and touchpoints, play a crucial role in treating chronic conditions.  Specialty drugs, often biologics administered...

Read More


More Articles

Understanding Multiple Sclerosis and the Role of Specialty Care

by Alivia Kaylor

Multiple sclerosis is an immune-mediated disease that affects nearly 1 million people in the United States and over 2.8 million worldwide. Given the complexity of treatment, specialty care teams play a vital role in disease management by...

Respiratory Medications, Understanding Options, and Indications

by Veronica Salib

Over the past couple of years, healthcare industry members have had to become fast experts on treating respiratory diseases. With the progression of the COVID-19 pandemic and the lingering pulmonary effects associated with infection,...

ACMA Announces Board Certification Program for Biologics, Biosimilars

by Veronica Salib

Biosimilars have gained significant traction in healthcare for being more affordable alternatives to biological products. Despite the importance and benefits of biosimilars, many providers are hesitant...

FDA Approves Relyvrio for ALS Treatment

by Veronica Salib

Yesterday, the FDA approved Relyvrio, an ALS drug developed by Amylyx Pharmaceuticals, after extensive discussions about the safety and efficacy of the drug. The drug was initially rejected by an FDA...

Antibiotic Overprescription Is Associated with Worse CKD Outcomes

by Veronica Salib

A recent study in JAMA Open Network looked at the relationship between fluoroquinolone — an antibiotic — dosage and adverse side effects in patients with CKD. The researchers found that...

Roche Developing High-Volume COVID-19 Antigen Testing Product

by Samantha McGrail

Roche recently announced that it will launch a new high-volume COVID-19 antigen test, which will be made available at the end of 2020 for markets accepting the CE Mark. The Elecsys SARS-CoV-2 Antigen...

FDA Authorizes Faster COVID-19 Antigen Test from Abbott

by Samantha McGrail

FDA recently issued an emergency use authorization to Abbott for the first COVID-19 antigen test where results can be read directly from the testing card.  The BinaxNOW Ag Card is fast and...

Revamping Biosimilar Reviews to Spur Drug Development in Oncology

by Samantha McGrail

Biosimilar reviews confirm any differences between a potential biosimilar and its reference product, but new research shows that these reviews may need to provide more information about efficacy to...

Recent Articles